CAS 1922098-69-8

Fórmula: C23H19ClF2N2O3

InChI: InChI=1S/C23H19ClF2N2O3/c24-18-6-8-19(9-7-18)27-21(29)17-12-23(25,26)14-28(13-17)22(30)16-4-1-3-15(11-16)20-5-2-10-31-20/h1-11,17H,12-14H2,(H,27,29)

Clave InChI: PMTPYUTZAJWGPE-UHFFFAOYSA-N

SMILES: C1C(CN(CC1(F)F)C(=O)C2=CC=CC(=C2)C3=CC=CO3)C(=O)NC4=CC=C(C=C4)Cl

CCG-222740

CAS: 1922098-69-8

CCG-222740

Fórmula: C₂₃H₁₉ClF₂N₂O₃

Pureza: ≥98%

Peso molecular: 444.86

Ref: 54-BUP09831

N-(4-Chlorophenyl)-5,5-difluoro-1-(3-(furan-2-yl)benzoyl)piperidine-3-carboxamide

CAS: 1922098-69-8

Fórmula: C₂₃H₁₉ClF₂N₂O₃

Pureza: 98%

Forma y color: Solid

Peso molecular: 444.8584

Ref: IN-DA01KJXC

CCG-222740

CAS: 1922098-69-8

CCG-222740 is an inhibitor of Rho/MRTF pathway

Fórmula: C₂₃H₁₉ClF₂N₂O₃

Pureza: 98.76%

Forma y color: Solid

Peso molecular: 444.858

Ref: TM-T7764

N-(4-Chlorophenyl)-5,5-difluoro-1-(3-(furan-2-yl)benzoyl)piperidine-3-carboxamide

CAS: 1922098-69-8

Fórmula: C₂₃H₁₉ClF₂N₂O₃

Pureza: 98%

Peso molecular: 444.86

Ref: 10-F547062

CCG-222740

CAS: 1922098-69-8

CCG-222740 is a small molecule inhibitor, which is derived from synthetic chemistry advancements aimed at developing targeted cancer therapies. It operates by modulating specific signaling pathways that are known to contribute to tumor growth and survival. Specifically, CCG-222740 targets the Rho GTPase family, which is involved in regulating cytoskeletal dynamics and cell proliferation.

Fórmula: C₂₃H₁₉ClF₂N₂O₃

Pureza: Min. 95%

Peso molecular: 444.86 g/mol

Ref: 3D-XBD09869